Mike Taylor

Mike Taylor is the Vice President of Toxicology. Mike has over 30 years in the pharmaceutical industry beginning with Syntex Research in Palo Alto, CA. Most recently, he was the Founder and Principal of NonClinical Safety Assessment, a consulting firm focusing on the safety evaluation of drugs and medical devices. Mike’s experience spans a variety of therapeutic areas, successfully supporting the development of both novel and repurposed therapeutics. He has held executive leadership positions at Roche Bioscience, Durect Corporation, Protein Design Labs, Alexza Pharmaceuticals, and Limerick BioPharma. Mike is currently a mentor in Stanford University’s SPARK program, providing pharmaceutical development guidance to students and aspiring entrepreneurs. He holds Ph.D. and M.S. degrees in toxicology from Utah State University with postdoctoral training at the CNRS of France and the NIH, is a member of the Society of Toxicology and the American College of Toxicology and is certified by the American Board of Toxicology. Mike is author/co-author of more than 50 publications, including peer-reviewed articles, book chapters, and abstracts.